title: Circulating peptide YY, weight loss, and glucose homeostasis after gastric bypass surgery in morbidly obese subjects.
abstract: OBJECTIVE
  To prospectively assess the relationship between circulating peptide YY (PYY), body weight, and glucose tolerance in severely obese subjects undergoing Roux-en-Y gastric bypass (RYGBP).
  
  
  BACKGROUND
  The mechanisms accounting for the beneficial effects of RYGBP on body weight and glucose homeostasis are not well understood.
  
  
  METHODS
  Prospective study on the response of PYY to a standardized test meal (STM) and its relationship with weight loss and glucose homeostasis (fasting plasma glucose, HbA1c, HOMA-IR, HOMA-B) in nondiabetic (n = 25) and diabetic (n = 10) severely obese subjects evaluated before, and at 6 and 52 weeks after RYGBP.
  
  
  RESULTS
  The PYY response to a STM significantly increased (P < 0.001) already at 6 weeks at a time when subjects despite presenting a significant weight loss (-14.6% +/- 1.2%) were still markedly obese. Despite massive weight loss (-43.0% +/- 2.3%), no further increase in the area under the curve of PYY was observed at 52 weeks after surgery (P = 0.44). The PYY response to a STM at 6 weeks after surgery significantly correlated (r = 0.489, P < 0.05) with the percent excess weight loss at 32.5 +/- 1.1 months after surgery. In contrast, no significant correlation was found between PYY and glucose homeostasis parameters in nondiabetic and diabetic patients.
  
  
  CONCLUSIONS
  Our data support the hypothesis that an increased PYY response after meal ingestion is involved in the sustained weight loss observed after RYGBP. In contrast, our data does not support PYY being relevant in the changes in glucose homeostasis occurring after this type of bariatric surgery.
authors.affiliation: Obesity Unit, Hospital Clínic Universitari, Barcelona, Spain.
authors.forename: Rosa
authors.initials: R
authors.lastname: Morínigo
authors.forename: Josep
authors.initials: J
authors.lastname: Vidal
authors.forename: Antonio M
authors.initials: AM
authors.lastname: Lacy
authors.forename: Salvadora
authors.initials: S
authors.lastname: Delgado
authors.forename: Roser
authors.initials: R
authors.lastname: Casamitjana
authors.forename: Ramon
authors.initials: R
authors.lastname: Gomis
mesh_terms: D000328:Adult; D015415:Biomarkers / Q000097:blood; D001786:Blood Glucose / Q000378:metabolism*; D005260:Female; D005500:Follow-Up Studies; D015390:Gastric Bypass / Q000379:methods*; D005951:Glucose Tolerance Test; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D009767:Obesity, Morbid / Q000097:blood* / Q000601:surgery; D019894:Peptide YY / Q000097:blood*; D011184:Postoperative Period; D011446:Prospective Studies; D011863:Radioimmunoassay; D016896:Treatment Outcome; D015431:Weight Loss / Q000502:physiology*
chemical_list: D015415:Biomarkers; D001786:Blood Glucose; D006442:Glycated Hemoglobin; D019894:Peptide YY; C517652:hemoglobin A1c protein, human